BioArctic AB (FRA:B9A) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B9A BioArctic AB FRA:B9A
60 GF Score
Price €28.92
! 2 Warning Signs
View Full Analysis

What is BioArctic AB Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:B9A
60GF Score
BioArctic AB FRA:B9A
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
60GF Score

Get the complete analysis for FRA:B9A

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.92
Price